Table 2. Comorbidity in populations at risk of breast, colon or lung cancer.
| Co-morbidity in at risk screening populations | Breast cancer (38) (N=237,938) (%) | Colon cancer (39) (N=271,670) (%) | Lung cancer—high risk1 (1) (N=10,054) (%) | Lung cancer—low risk2 (40) (N=8,250) (%) |
|---|---|---|---|---|
| Heart disease* | 6,848 (2.9) | 24,477 (9.0) | 1,327 (13.2) | 205 (2.5) |
| Stroke | 8,479 (3.6) | 21,852 (8.0) | 302 (3.0) | 211 (2.6) |
| Diabetes | 7,734 (3.3) | 16,846 (6.2) | 972 (9.7) | 665 (8.1) |
| Chronic lung disease# | 9,804 (4.1) | 17,061 (6.3) | 2,218 (22.1) | 414 (5.0) |
| Other cancers | 8,967 (3.8) | 22,517 (8.3) | 417 (4.1) | 417 (5.1) |
*, includes a history of myocardial infarction and heart failure; #, includes a history of chronic obstructive pulmonary disease, emphysema, chronic bronchitis and adult asthma; 1, high risk population of the NLST-ACRIN subgroup for lung cancer screening (≥30 pack years) (1); 2, low risk population of the PLCO cancer screening study (never and ever smokers) (40). NLST, National Lung Screening Trial; ACRIN, American College of Radiology Imaging Network.